Showing results (241-250 of 2,337) with videos related to
Sort By:
Pageof 234
Clinical Lung Cancer|December 5, 2003
The role of farnesyltransferase inhibitors in lung cancer therapyGrace K Dy, Alex A AdjeiClinical Lung Cancer|January 11, 2005
Current development of adjuvant treatment of non-small-cell lung cancerGiorgio V Scagliotti, Silvia NovelloClinical Lung Cancer|January 11, 2005
Cetuximab as a single agent or in combination with chemotherapy in lung cancerEdward S KimClinical Lung Cancer|January 11, 2005
CT-2103: a novel macromolecular taxane with potential advantages compared with conventional taxanesCorey J LangerClinical Lung Cancer|January 11, 2005
Use of proteasome inhibition in the treatment of lung cancerDavid P SchenkeinClinical Lung Cancer|October 13, 2004
Early-stage non-small-cell lung cancer: current perspectives in combined-modality therapyPaul A BunnClinical Lung Cancer|October 13, 2004
Gemcitabine in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy: a phase II California cancer consortium trialPrimo N Lara, Paul H Gumerlock, Philip C Mack, et al.Clinical Lung Cancer|October 1, 2008
Unusual tumor response and toxicity from radiation and concurrent erlotinib for non-small-cell lung cancerAkash Nanda, Dora C Dias-Santagata, Hannah Stubbs, et al.Clinical Lung Cancer|June 7, 2017
Comparison of Radiotherapy and Chemoradiotherapy for Locoregional Recurrence of Non-small-cell Lung Cancer Developing After SurgeryShinji Nakamichi, Hidehito Horinouchi, Tetsuhiko Asao, et al.Clinical Lung Cancer|May 29, 2017
Coexistence of EGFR, KRAS, BRAF, and PIK3CA Mutations and ALK Rearrangement in a Comprehensive Cohort of 326 Consecutive Spanish Nonsquamous NSCLC PatientsPaloma Martín Martorell, Marisol Huerta, Amparo Compañ Quilis, et al.Pageof 234